Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Q-Urol for radiation-induced prostatitis
NCT04252625Phase 2Terminated
- Sponsor
- University of Utah
- Start
- Nov 2022
- Primary completion
- Dec 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Q-Urol in prostatitis, sponsored by University of Utah. Started Nov 2022; status: terminated.
02
Drugs
Q-Urol
03
Conditions
prostatitis
Beyond the preview
Go deeper on NCT04252625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04252625.